KOC
GILD icon

Koss-Olinger Consulting’s Gilead Sciences GILD Stock Holding History

Koss-Olinger Consulting’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$592K Sell
4,245
-220
-5% -$30.8K 0.05% 142
2025
Q4 		$548K Sell
4,465
-13,702
-75% -$1.67M 0.04% 160
2025
Q3 		$2.01M Hold
18,167
– – 0.17% 70
2025
Q2 		$2.01M Sell
18,167
-644
-3% -$68.5K 0.17% 70
2025
Q1 		$2.11M Sell
18,811
-19,438
-51% -$2.01M 0.18% 66
2024
Q4 		$3.53M Buy
38,249
+6,782
+22% +$611K 0.31% 44
2024
Q3 		$2.64M Sell
31,467
-1,649
-5% -$126K 0.23% 55
2024
Q2 		$2.27M Buy
33,116
+27,716
+513% +$1.85M 0.21% 62
2024
Q1 		$396K Sell
5,400
-16,395
-75% -$1.26M 0.21% 42
2023
Q4 		$1.77M Buy
21,795
+13,432
+161% +$1.05M 0.17% 64
2023
Q3 		$627K Buy
8,363
+5,438
+186% +$418K 0.09% 117
2023
Q2 		$225K Hold
2,925
– – 0.03% 237
2023
Q1 		$243K Sell
2,925
-121
-4% -$10K 0.03% 206
2022
Q4 		$261K Buy
+3,046
New +$241K 0.04% 172
2022
Q2 		– Sell
-3,573
Closed -$212K – 196
2022
Q1 		$212K Sell
3,573
-1,377
-28% -$88K 0.03% 180
2021
Q4 		$359K Buy
4,950
+726
+17% +$50K 0.06% 141
2021
Q3 		$295K Buy
+4,224
New +$297K 0.05% 173

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Koss-Olinger Consulting's GILD Position: Q1 2026 in Review

Koss-Olinger Consulting reduced its Gilead Sciences (GILD) stake by 4.9% in Q1 2026, selling an estimated $30.8K and leaving 4,245 shares worth $592K. The position accounts for 0.05% of the portfolio, ranked #142.

Koss-Olinger Consulting first reported a position in GILD in Q3 2021 and has held it in 17 quarters since. The position peaked at $3.53M in Q4 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Koss-Olinger Consulting held 4,245 shares of Gilead Sciences worth $592K as of Q1 2026.
  • Koss-Olinger Consulting sold 220 Gilead Sciences shares in Q1 2026, an estimated $30.8K.
  • Gilead Sciences made up 0.05% of Koss-Olinger Consulting's portfolio in Q1 2026, its #142 holding.
  • Koss-Olinger Consulting first reported a position in Gilead Sciences in Q3 2021 and has held it in 17 quarters since.
  • Koss-Olinger Consulting's Gilead Sciences position peaked at $3.53M in Q4 2024.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Koss-Olinger Consulting's 13F filing for Q1 2026, filed 7 May 2026.